Similar to PD-1, TIGIT, a novel immune checkpoint, which is mainly expressed on NKs, CD8+ T cells, CD4+ T cells, and Treg cells (63), is well known for its important role in tumor immunity and autoimmune diseases (64–66). Here, CD4 is linked to neoplasm.